NLARx In the News
BREAKING NEWS: 1st Circuit Denies IMS Motion for Rehearing in Data Mining Case More
Op Ed: Drug Manufacturers Shouldn't Be Immune If Products Cause Harm More
NLARx Attorney Sean Flynn Testifies before the Washington DC Health Committee More
|
In the States
OHIO: State Auditor, Medicaid Director Spar Over Possible Savings More
Cleveland Clinic Discloses Business Ties
Of Physicians as Part of Transparency Move More
MARYLAND: Maryland Offering Financial Aid To Seniors Paying For Prescription Drugs More
NEW YORK: New York Invests to Recover $551 Million from Medicaid Fraud More
ALABAMA: Attorney General Sues CMS More
MASSACHUSETTS: Regulators Propose Rules to Curb
Drug, Device Company Gifts to Providers More
TEXAS: State Sues J&J's Janssen Pharma More
State Mulls Doc-Disclosure Law More
WISCONSIN: University of Wisconsin Health Seeks to Reveal Doctors' Pay from Drug Companies More
PENNSYLVANIA: Former State Pharmacist Convicted Over Conflicts Of Interest More
WEST VIRGINIA: State Project Promotes Generic Drugs More
|
Outrage of the Week
FDA Lax on Examining Potential Conflicts of Interest in Drug Trials, HHS Report Says More
|
Book Review
Drug Companies & Doctors: A Story of Corruption More
|
Prices and Access to Healthcare
Health Spending Continues To Explode More
More Struggle with Medical Debt As Recession Deepens More
Vets Often Forgo Medication When Co-Pays Rise More
2007 Health Care Spending Increased at Lowest Rate in Nine Years, Study Finds More
Prescription Drug Spending Still Rises But at Lower Rate More
Flood of Generics Slows Cost Increases More
Grocer to Offer Free Antibiotics to Customers for Three Months More
Ovation's Drug Price Hike Leads to Lawsuit More
|
Advertising and Marketing
PhRMA Adopts New Voluntary Guidelines on Physician Gifting Practices More
PhRMA Isn't Waiting for Disclosure Law More
Direct-to-Consumer Drug Ads Losing Their Punch More
Court Holds Off-Label Promotion Claims
Not Actionable in Suit Against Drugmaker More
FDA Allows Off-Label Journal Promos More
Glaxo Chief to Cut Back on TV Ads More
Edwards Lifesciences To Disclose Ties To Doctors More
|
Conflicts of Interest
New England Journal of Medicine Alters Policies In Response to Conflicts Complaints More
Series Examines Financial
Ties Between Physicians, Pharmaceutical Industry More
Grassley Letters Question Wyeth on Paying Company to Draft Favorable Journal Articles More
New Questions About AARP's Growing Insurance Business More
Conflicts Of Interest & University Of Minnesota More
University of Minnesota Doctor on Ethics Panel Was Disciplined More
Harvard Anti-Aging Researcher Quits Shaklee Advisory Board More
Embattled Emory Psychiatrist Steps Down More
New York Times Misses Conflict of Interest in Story on Given Imaging More
Odds & Ends on Conflicts of Interest from Integrity In Science Watch More
|
Pharma Watch
Washington Post Examines Drug Industry Health Care Efforts More
Industry and Advocates Weigh In on FDA Leader More
Merck Asks FDA to Expand Gardasil Use More
Glaxo To End Political Contributions More
Pfizer Spent $3.1 Million Lobbying in 3rd Quarter More
J & J Spent $1.5M Lobbying in the 3rd Quarter More
Merck Spent $1.1M Lobbying in 3rd Quarter More
For Some Drugmakers, The World Will Be Flat More
Pfizer Must Pay $38M For Stealing Trade Secrets More
Pfizer Project Looks at Side Effects More
Bristol-Myers Will Layoff Yet Another 10% More
|
Fraud and Abuse
FTC Sues Ovation Over Alleged Monopoly on Prescription Drugs for Infants More
Federal Trial Court Approves Class Action
In Antitrust Lawsuit Brought by K-Dur 20 Purchasers More
Teva Settles MassHealth Fraud Lawsuit More
|
PBM Watch
CMS Finalizes Medicare Rule To Stop PBM
Practice That Inflates Drug Costs More
Medicare Slows Reaching 'Doughnut Hole' More
Medco Health CEO Sees Opportunity In US Health Policy Reform More
Ameriprise Financial Names Express Scripts (ESRX) a Top Pick for 2009 More |
Medicare
CMS Proposes Ban on Additional Charges for Brand-Name Drugs Under Part D More
WellPoint Barred from Enrolling New Patients in Medicare More
Medicare Clarifies Parrt D 'Negotiated Prices' More
Soaring Costs for Colorado Medicare Drug Plans
More
|
Medicaid
The Worst Places To Be Sick And Poor More
Many States Experience Increases in Medicaid Enrollment as Tax Revenues Fall More
States Consider Further Cuts to Medicaid More
Amgen To Pay Wisconsin $1.7M For Fraud More
|
Patents and Generics
Large Pharmacy Chains Aggressively Promote Generic Drug Discounts More
Giant Food To Offer Generic Antibiotics at No Cost for Three Months More
Wegmans Food Markets To Offer No-Cost Generic Antibiotics Through March More
|
Safety and Clinical Trials
FDA Scientists Plea for Agency Reform More
More U.S. Residents Seeking To Participate in Paid Clinical Trials as Economy Weakens More
Drug Industry Not Celebrating Drug-Safety Crusader Sidney Wolfe Appointment More
Researchers Find Reporting Bias
In Drug Trials More
J&J, Vanderbilt Team Up on Schizophrenia Drugs More
Elsevier To Investigate Medical Journal Articles Allegedly Ghostwritten by Wyeth More
Study links Fosamax to Jawbone Problems More
FDA Warns about Some Diet Pills Sold On Web More
Of Antibiotics and Globalisation More
FDA Decision Not to Require Clinical Data
For Heart Device Criticized by Cardiologists More
FDA Mandates Warnings for Epilepsy Medicines More
Off-Label Avastin Use Tied To Eye Injuries More
New Diabetes Meds Must Have Heart Risk Info More
Study: Consumer Info Leaflets Proved with New Prescriptions Provide
Inconsistent Information More
Time Bomb? The Clinical Trial 'Gold Rush' In India More
|
Electronic Records
Study Finds Big Savings for E-Prescribing More
Health Care IT Trade Group Issues Recommendations for Obama, Congress on Technology More
|
Commentary
JAMA Commentary Examines Terminally Ill Patients' Access to Experimental Drugs More
|
